NCT06597071View on ClinicalTrials.gov

Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely

NAEnrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

December 1, 2025

Conditions
Parkinson DiseaseProgressive Supranuclear Palsy(PSP)Multiple System Atrophy
Interventions
OTHER

NeuraLight PD

NeuraLight software-based platform for PD patients

OTHER

NeuraLight PSP

NeuraLight software-based platform for PSP patients

OTHER

NeuraLight MSA

NeuraLight software-based platform for MSA patients

OTHER

NeuraLight

NeuraLight software-based platform

Trial Locations (1)

Unknown

Instituto de Biomedicina de Sevilla (IBiS), Seville

Sponsors

Lead Sponsor

NeuraLight
All Listed Sponsors
collaborator

Hospitales Universitarios Virgen del Rocío

OTHER

lead

NeuraLight

INDUSTRY

NCT06597071 - Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely | Biotech Hunter | Biotech Hunter